Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Genes, Chromosomes & Cancer|April 25, 2018
Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanomaSerena Patrone, Irena Maric, Mariangela Rutigliani, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 19, 2023
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cellsAdriana Amaro, Francesco Reggiani, Daniela Fenoglio, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2022
In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutationsFrancesca Piaggio, Michela Croce, Francesco Reggiani, et al.
Journal of Occupational Medicine and Toxicology (London, England)|February 15, 2018
Diagnosis, monitoring and prevention of exposure-related non-communicable diseases in the living and working environment: DiMoPEx-project is designed to determine the impacts of environmental exposure on human healthLygia Therese Budnik, Balazs Adam, Maria Albin, et al.
Molecular Cancer|June 10, 2008
Involvement of GTA protein NC2beta in neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferationCinzia Di Pietro, Marco Ragusa, Davide Barbagallo, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2018
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup studyMaria Pia Pistillo, Vincenzo Fontana, Anna Morabito, et al.
Frontiers in Immunology|April 28, 2017
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup StudyPaola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Frontiers in Immunology|March 14, 2018
Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup StudyPaola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Pageof 6